diosgenin has been researched along with Bone Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Chen, L; Cheng, C; Ding, Q; Liu, X; Mo, F; Peng, G; Wang, J; Yang, S; Zhang, W | 1 |
| Chang, J; Hu, S; Li, Y; Shi, Q; Wang, H; Wang, X; Wang, Y; Yang, Y | 1 |
| Jia, Q; Li, W; Liu, W; Shen, J; Su, Q; Wang, Y; Yin, J; Zhang, J; Zhang, X; Zhao, Z | 1 |
| Chen, J; Duan, H; Fang, X; Hou, D; Jiang, T; Liu, P; Long, C; Zhou, H | 1 |
| Chang, J; Li, Y; Lu, S; Shi, Q; Wang, C; Wang, H; Wang, X; Wang, Y; Yang, Y; Yang, Z; Zeng, Q; Zhao, D; Zhao, Y; Zimmerman, J | 1 |
| Chang, IL; Chen, CL; Chen, HY; Cheng, CH; Hsieh, CP; Shen, TS; Tseng, SC; Wu, CC | 1 |
| Battu, S; Beneytout, JL; Cardot, PJ; Corbière, C; Liagre, B | 1 |
7 other study(ies) available for diosgenin and Bone Cancer
| Article | Year |
|---|---|
Dioscin inhibits the growth of human osteosarcoma by inducing G2/M-phase arrest, apoptosis, and GSDME-dependent cell death in vitro and in vivo.
Topics: Apoptosis; Bone Neoplasms; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Diosgenin; G2 Phase Cell Cycle Checkpoints; Humans; Osteosarcoma; Pyroptosis; Receptors, Estrogen | 2020 |
Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Diosgenin; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Male; Mice; Mice, Nude; Osteosarcoma; Protein Kinase Inhibitors; Pyridines; Pyrimidines; RNA, Small Interfering; Signal Transduction; Wnt Proteins; Xenograft Model Antitumor Assays | 2017 |
Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
Topics: Adolescent; Adult; Animals; Antineoplastic Agents; beta Catenin; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Diosgenin; Female; Glycogen Synthase Kinase 3; Humans; Male; Mice; Mice, Nude; Middle Aged; Neoplastic Stem Cells; Osteosarcoma; Proto-Oncogene Proteins c-akt; Signal Transduction; Young Adult | 2018 |
Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cdc20 Proteins; Cell Line, Tumor; Cell Movement; Diosgenin; Humans; Neoplasm Invasiveness; Osteosarcoma | 2019 |
Molecular mechanisms of Polyphyllin I-induced apoptosis and reversal of the epithelial-mesenchymal transition in human osteosarcoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bone Neoplasms; Cell Line, Tumor; Diosgenin; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Liliaceae; Molecular Targeted Therapy; Osteosarcoma; Proteasome Endopeptidase Complex; Up-Regulation | 2015 |
Methyl Protodioscin Induces Apoptosis in Human Osteosarcoma Cells by Caspase-Dependent and MAPK Signaling Pathways.
Topics: Apoptosis; bcl-2-Associated X Protein; Bone Neoplasms; Caspase 3; Caspase 9; Cell Line, Tumor; Dioscorea; Diosgenin; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Osteosarcoma; Phosphorylation; Plant Extracts; Saponins | 2017 |
SdFFF monitoring of cellular apoptosis induction by diosgenin and different inducers in the human 1547 osteosarcoma cell line.
Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Diosgenin; Humans; Osteosarcoma | 2004 |